VeeralHareshAjmeraMD

Gastroenterology • La Jolla, CA

Hepatology & Liver Transplantation

Associate Professor of Medicine-University of California, San Diego Medical Director of Liver Transplantation

Join to view full profile

Dr. Ajmera is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ajmera's full profile

Already have an account?

Office
9350 Campus Point Dr
La Jolla, CA 92037
Phone+1 619-543-1884

Fax+1 619-543-3183
Is this information wrong?

Education & Training

University of California (San Francisco)Fellowship, Gastroenterology, 2013 - 2016
Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2013
University of Texas Southwestern Medical SchoolClass of 2010

Certifications & Licensure

CA State Medical License 2013 - 2025
MA State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
American Board of Internal Medicine Transplant Hepatology

Clinical Trials

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2021 Aug 12
Completed
Phase 2
Roles: Contact

Publications & Presentations

PubMed

A prospective study on the prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States.
Nikita Mittal, Harris Siddiqi, Egbert Madamba, Lisa Richards, Ricki Bettencourt, Veeral Ajmera, Rohit Loomba> ;Alimentary Pharmacology & Therapeutics. 2024 Apr 8
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease.
Nabil Noureddin, Daniel Q Huang, Ricki Bettencourt, Harris Siddiqi, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Me...> ;Alimentary Pharmacology & Therapeutics. 2024 Apr 3
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease.
Rohit Loomba, Ginger Clark, Jeff Teckman, Veeral Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mand...> ;Alimentary Pharmacology & Therapeutics. 2024 May 1
2 citations
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States.
Vilar-Gomez, E., Wilson, L., Gawrieh, S., Woreta, T., Lake, J., Price, J., Naggie, S., Sterling, R., Heath, S., Corey, K., Cachay, E., Ajmera, V., Tonascia, J., Sulkow...> ;Alimentary Pharmacology & Therapeutics. 2024 Mar 1
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes.
Veeral Ajmera, Kaleb Tesfai, Erick Sandoval, Scarlett Lopez, Vanessa Cervantes, Egbert Madamba, Ricki Bettencourt, Pinelopi Manousou, Lisa Richards, Rohit Loomba, Loom...> ;Hepatology. 2024 May 1
Acute Fulminant Hepatic Failure in 23-Year-Old Female Taking Homeopathic Remedy.
Nicole Hamilton Goldhaber, Abbey Barnard Giustini, Justin Parekh, Kristin L Mekeel, Veeral Ajmera> ;Journal of Investigative Medicine High Impact Case Reports. 2023 Oct 16
2 citations
MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-ana...
Nabil Noureddin, Veeral Ajmera, Jaclyn Bergstrom, Richele Bettencourt, Daniel Q Huang, Harris Siddiqi, Abdul M Majzoub, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima...> ;Alimentary Pharmacology & Therapeutics. 2023 Nov 1
3 citations
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Daniel Q Huang, Veeral Ajmera, Christian Tomaszewski, Andrew LaFree, Ricki Bettencourt, Wesley K Thompson, Davey M Smith, Atul Malhotra, Ravindra L Mehta, Vaishal Toli...> ;Advances in Therapy. 2023 Nov 1
Reply to: "Non-invasive testing for advanced fibrosis in patients with diabetes with fatty liver disease needs further evaluation of cut-off values".
Veeral Ajmera, Rohit Loomba> ;Journal of Hepatology. 2023 Nov 1
2 citations
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
Beom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem K Oz, Ayse Erden, Emily Truong...> ;Hepatology. 2023 Dec 1
5 citations
Advances in the genetics of nonalcoholic fatty liver disease.
Veeral Ajmera, Rohit Loomba> ;Current Opinion in Gastroenterology. 2023 May 1
Editorial: "being normal weight each day keeps NAFLD and fibrosis away"-the importance of reducing cumulative exposure to overweight. Authors' reply.
Veeral Ajmera> ;Alimentary Pharmacology & Therapeutics. 2023 May 1
Towards omics-based risk assessment in NAFLD.
Veeral Ajmera> ;Nature Metabolism. 2023 Apr 1
10 citations
Genomic analysis of lean individuals with NAFLD identifies monogenic disorders in a prospective cohort study.
Melanie Zheng, Daniel Q Huang, Chigoziri Konkwo, Saaket Agrawal, Amit V Khera, Rohit Loomba, Sílvia Vilarinho, Veeral Ajmera> ;JHEP Reports. 2023 Apr 1
4 citations
Longitudinal association between overweight years, polygenic risk and NAFLD, significant fibrosis and cirrhosis.
Veeral Ajmera, Na Wang, Hanfei Xu, Ching-Ti Liu, Michelle T Long> ;Alimentary Pharmacology & Therapeutics. 2023 May 1
3 citations
Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: Short-term outcome in a first-i...
Aleah L Brubaker, Marcus A Urey, Raeda Taj, Justin R Parekh, Jennifer Berumen, Mark Kearns, Mita Shah, Adnan Khan, Yuko Kono, Veeral Ajmera, Pranab Barman, Hao Tran, E...> ;American Journal of Transplantation. 2023 Feb 1
Reply to: "Screening for NAFLD and its severity in type 2 diabetic patients: Value of magnetic resonance imaging and outstanding issues".
Veeral Ajmera, Rohit Loomba> ;Journal of Hepatology. 2023 May 1
2 citations
Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review.
Kelly Torosian, Esha Lal, Arthur Kavanaugh, Rohit Loomba, Veeral Ajmera, Monica Guma> ;Seminars in Arthritis and Rheumatism. 2023 Apr 1
54 citations
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes.
Veeral Ajmera, Sandra Cepin, Kaleb Tesfai, Heather Hofflich, Karen Cadman, Scarlett Lopez, Egbert Madamba, Ricki Bettencourt, Lisa Richards, Cynthia Behling, Claude B ...> ;Journal of Hepatology. 2023 Mar 1
11 citations
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease.
Nobuharu Tamaki, Noora Ahlholm, Panu K Luukkonen, Kimmo Porthan, Suzanne R Sharpton, Veeral Ajmera, Yuko Kono, Shravan Dave, Aijaz Ahmed, Vinay Sundaram, Michael J Wil...> ;The Journal of Clinical Investigation. 2022 Nov 1
1 citations
Single-center Experience on Nonlung Solid Organ Transplantation From SARS-CoV-2-positive Donors.
Karina Covarrubias, Aleah L Brubaker, Kristin Mekeel, Victor Pretorius, Mita Shah, Eric Adler, Veeral Ajmera, Gabriel T Schnickel, Saima Aslam> ;Transplantation. 2023 Jan 1
39 citations
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Ana...
Veeral Ajmera, Beom Kyung Kim, Kun Yang, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru O...> ;Gastroenterology. 2022 Oct 1
29 citations
Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab.
Gabriel T Schnickel, Kassandra Fabbri, Mojgan Hosseini, Michael Misel, Jennifer Berumen, Justin Parekh, Kristin Mekeel, Yalda Dehghan, Yuko Kono, Veeral Ajmera> ;American Journal of Transplantation. 2022 Jun 1
7 citations
The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre- and Post-liver Transplant Outcomes.
Shravan Dave, Kun Yang, Gabriel T Schnickel, Yuko Kono, Fanny Delebecque, Deyna Arellano, Amy Liu, Xinlian Zhang, Xin M Tu, Veeral Ajmera> ;Transplantation. 2022 Jun 1
17 citations
Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholi...
Veeral Ajmera, Khang Nguyen, Nobuharu Tamaki, Suzanne Sharpton, Ricki Bettencourt, Rohit Loomba> ;Therapeutic Advances in Gastroenterology. 2022 Jan 1
Join now to see all

Press Mentions

New Analysis Shows That Women Who Develop Diabetes While Pregnant Are Likely to Develop Fatty Liver DiseaseAugust 10th, 2020
Longer Breastfeeding Tied to Lower Risk of Liver DiseaseDecember 13th, 2018
Breastfeeding for Six Months Can Save You from Fatty Liver Disease, Shows StudyNovember 3rd, 2018
Join now to see all